ONE EXAMPLE OF HOW TOUGH TIMES ARE for companies offering proprietary or patent-protected tests is the acquisition of LipoScience by Laboratory Corporation of America in a deal that was disclosed last September. It was announced that LabCorp would pay $85 million, or $5.25 per share, for LipoScience, which analysts said valued the company at just […]
- Lab Market Update
LipoScience Could Find No Other Interested Buyer than LabCorp
Specialty lab company was struggling to convince physicians and health insurers of its test’s value
- By Joseph Burns
- > From the Volume XXI No.16 - November 24, 2014 Issue
